Published in Mol Endocrinol on July 01, 1997
Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol (1999) 4.91
High-mobility group box 1 and cancer. Biochim Biophys Acta (2010) 3.11
High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev (1998) 2.40
High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol (1998) 2.38
High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal (2011) 2.19
HMGB1 in health and disease. Mol Aspects Med (2014) 1.67
Mechanism for specificity by HMG-1 in enhanceosome assembly. Mol Cell Biol (2000) 1.44
Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements. Mol Endocrinol (2006) 1.26
HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int J Clin Exp Pathol (2009) 1.00
Functional interactions between a phage histone-like protein and a transcriptional factor in regulation of phi29 early-late transcriptional switch. Genes Dev (1999) 0.99
Distinct regulatory mechanisms of eukaryotic transcriptional activation by SAGA and TFIID. Biochim Biophys Acta (2010) 0.97
The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription. Nucleic Acids Res (2003) 0.96
A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain. J Biol Chem (2009) 0.96
Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding. Nucleic Acids Res (2008) 0.94
Ménage à Trois in stress: DAMPs, redox and autophagy. Semin Cancer Biol (2013) 0.89
Isolation of novel coregulatory protein networks associated with DNA-bound estrogen receptor alpha. BMC Mol Biol (2008) 0.89
Expanding the paradigm for estrogen receptor binding and transcriptional activation. Mol Endocrinol (2011) 0.83
[Immunohistochemical characterization of salivary gland tumors with tissue micro-arrays]. Pathologe (2005) 0.80
The implication and potential applications of high-mobility group box 1 protein in breast cancer. Ann Transl Med (2016) 0.79
Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet (2001) 17.43
DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev (1998) 7.78
Enzyme recruitment in evolution of new function. Annu Rev Microbiol (1976) 6.95
Dynamic binding of histone H1 to chromatin in living cells. Nature (2000) 4.91
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene (2000) 4.90
Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol (2000) 3.55
Growth retardation and tumour inhibition by BRCA1. Nat Genet (1996) 3.47
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer (1993) 3.33
Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res (1994) 3.18
Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med (1994) 3.09
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet (1995) 2.91
History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst (2000) 2.82
Control of aromatic acid biosynthesis in Bacillus subtilis: sequenial feedback inhibition. J Bacteriol (1966) 2.65
A signature for the HMG-1 box DNA-binding proteins. Bioessays (1993) 2.50
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol (1996) 2.50
High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev (1998) 2.40
Comparative control of a branch-point enzyme in microorganisms. J Bacteriol (1967) 2.39
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. Histopathology (2000) 2.27
Metabolic interlock. The dual function of a folate pathway gene as an extra-operonic gene of tryptophan biosynthesis. J Biol Chem (1972) 2.20
Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. Cancer Res (2000) 2.18
The transcriptionally-active MMTV promoter is depleted of histone H1. Nucleic Acids Res (1992) 2.16
Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci (2001) 2.15
Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation (2001) 2.10
Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res (2000) 2.08
Enzymological basis for herbicidal action of glyphosate. Plant Physiol (1982) 2.04
Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer (1995) 2.01
Orthologs and paralogs - we need to get it right. Genome Biol (2001) 1.95
Electron microscopic analysis of chromosome metabolism in the Drosophila melanogaster embryo. Cold Spring Harb Symp Quant Biol (1978) 1.93
Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res (1998) 1.91
Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res (2001) 1.87
Dual enzymatic routes to L-tyrosine and L-phenylalanine via pretyrosine in Pseudomonas aeruginosa. J Biol Chem (1977) 1.86
Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res (1998) 1.84
Antibodies against chromosomal HMG proteins stain the cytoplasm of mammalian cells. Cell (1979) 1.82
Regulatory enzymes of aromatic amino acid biosynthesis in Bacillus subtilis. I. Purification and properties of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetase. J Biol Chem (1966) 1.82
The regulation of tryptophan biosynthesis in Pseudomonas aeruginosa. Mol Gen Genet (1973) 1.80
The intracellular distribution and function of the high mobility group chromosomal proteins. Exp Cell Res (1985) 1.79
Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin Cancer Res (1996) 1.77
Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res (1998) 1.76
When and to what end do pathologists agree? J Natl Cancer Inst (1998) 1.76
Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol (2000) 1.74
BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J Biol Chem (1999) 1.71
Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Eur Respir J (2009) 1.68
Metabolic interlock. Regulatory interactions exerted between biochemical pathways. J Biol Chem (1969) 1.67
Chloroplasts of higher plants synthesize L-phenylalanine via L-arogenate. Proc Natl Acad Sci U S A (1986) 1.65
Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst (1995) 1.64
V(D)J recombination: modulation of RAG1 and RAG2 cleavage activity on 12/23 substrates by whole cell extract and DNA-bending proteins. J Exp Med (1997) 1.59
Regulatory enzymes of aromatic amino acid biosynthesis in Bacillus subtilis. II. The enzymology of feedback inhibition of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetase. J Biol Chem (1966) 1.58
Presentation of a new instrument: the diagnostic headache diary. Cephalalgia (1992) 1.57
Comparative regulation of isoenzymic 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetases in microorganisms. J Bacteriol (1968) 1.56
A biochemical basis for apparent abortive transformation in Bacillus subtilis. Genetics (1968) 1.55
Effects of endovascular radiation from a beta-particle-emitting stent in a porcine coronary restenosis model. A dose-response study. Circulation (1996) 1.53
Chromosomal protein HMG-14. Identification, characterization, and chromosome localization of a functional gene from the large human multigene family. J Biol Chem (1989) 1.53
Chromosomal protein HMG-17. Complete human cDNA sequence and evidence for a multigene family. J Biol Chem (1986) 1.51
Differentially Regulated Isozymes of 3-Deoxy-d-arabino-Heptulosonate-7-Phosphate Synthase from Seedlings of Vigna radiata [L.] Wilczek. Plant Physiol (1985) 1.51
Blue-green bacteria synthesise L-tyrosine by the pretyrosine pathway. Nature (1974) 1.51
The Two-Isozyme System of 3-Deoxy-d-arabino-Heptulosonate 7-Phosphate Synthase in Nicotiana silvestris and Other Higher Plants. Plant Physiol (1986) 1.49
Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat Neurosci (1999) 1.49
Diversity in the routing and regulation of complex biochemical pathways as indicators of microbial relatedness. Crit Rev Microbiol (1982) 1.49
Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading. Cancer (1984) 1.49
Metabolic interlock. The influence of histidine on tryptophan biosynthesis in Bacillus subtilis. J Biol Chem (1970) 1.48
BRCA1-associated growth arrest is RB-dependent. Proc Natl Acad Sci U S A (1999) 1.47
Mitotic phosphorylation prevents the binding of HMGN proteins to chromatin. Mol Cell Biol (2001) 1.47
Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res (1992) 1.47
MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology (1993) 1.46
Reactive spindle cell nodules of the breast after core biopsy or fine-needle aspiration. Am J Clin Pathol (2000) 1.45
A 10-year analysis of "revenues," costs, staffing, and workload in an academic medical center clinical chemistry laboratory. Clin Chem (1993) 1.45
Ductal carcinoma in situ of the breast: understanding the misunderstood stepchild. JAMA (1996) 1.42
Alleviation of histone H1-mediated transcriptional repression and chromatin compaction by the acidic activation region in chromosomal protein HMG-14. Mol Cell Biol (1997) 1.41
Isolation and preparation of pretyrosine, accumulated as a dead-end metabolite by Neurospora crassa. J Bacteriol (1977) 1.41
The branch point metabolite for pyocyanine biosynthesis in Pseudomonas aeruginosa. J Gen Microbiol (1972) 1.40
Pseudomonas aeruginosa possesses homologues of mammalian phenylalanine hydroxylase and 4 alpha-carbinolamine dehydratase/DCoH as part of a three-component gene cluster. Proc Natl Acad Sci U S A (1994) 1.40
Stimulation of RNA polymerase II elongation by chromosomal protein HMG-14. Science (1994) 1.39
[Decreased pain threshold and tolerance in patients with chronic tension headache]. Ugeskr Laeger (1997) 1.38
Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res (1994) 1.38
Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer (1989) 1.36
Species and organ specificity in very lysine-rich histones. J Biol Chem (1968) 1.36
Immunological relatedness of high mobility group chromosomal proteins from calf thymus. J Biol Chem (1978) 1.35
Nucleosome core binding region of chromosomal protein HMG-17 acts as an independent functional domain. J Mol Biol (1992) 1.35
Transcription factor FoxA (HNF3) on a nucleosome at an enhancer complex in liver chromatin. J Biol Chem (2001) 1.31
The molecular aggregation of anthranilate synthase in Bacillus subtilis. Biochem Biophys Res Commun (1970) 1.31
The histone acetyltransferase activity of human GCN5 and PCAF is stabilized by coenzymes. J Biol Chem (1997) 1.31
Evolution of aromatic amino acid biosynthesis and application to the fine-tuned phylogenetic positioning of enteric bacteria. J Bacteriol (1990) 1.31
The footprint of chromosomal proteins HMG-14 and HMG-17 on chromatin subunits. J Mol Biol (1994) 1.29
Enzymology of l-Tyrosine Biosynthesis in Mung Bean (Vigna radiata [L.] Wilczek). Plant Physiol (1979) 1.28
Intracellular roles of microbial aminotransferases: overlap enzymes across different biochemical pathways. Crit Rev Microbiol (1981) 1.27
Metabolic interlock. The role of the subordinate type of enzyme in the regulation of a complex pathway. J Biol Chem (1971) 1.27
The evolutionary pattern of aromatic amino acid biosynthesis and the emerging phylogeny of pseudomonad bacteria. J Mol Evol (1983) 1.26
Significance of altered carbon flow in aromatic amino acid synthesis: an approach to the isolation of regulatory mutants in Pseudomonas aeruginosa. J Bacteriol (1972) 1.24
Intramolecular activation of porcine pepsinogen. J Biol Chem (1971) 1.24